Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder
ICD-10 F13.25 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder.
F13.25 refers to a condition characterized by a dependence on sedative, hypnotic, or anxiolytic substances, which leads to the development of a psychotic disorder induced by these substances. Patients with this diagnosis often exhibit symptoms such as hallucinations, delusions, and severe mood disturbances that are directly attributable to the use of these medications. The dependence may manifest as a compulsive need to consume these substances, leading to significant impairment in social, occupational, or other important areas of functioning. Withdrawal symptoms can include anxiety, agitation, and seizures, which may further complicate the clinical picture. Treatment typically involves a combination of detoxification, psychological support, and rehabilitation programs aimed at addressing both the substance use disorder and the associated psychotic symptoms. Clinicians must carefully monitor patients for both withdrawal and the potential for relapse, as well as the need for ongoing psychiatric care.
Detailed psychiatric evaluations, including mental status exams and history of substance use.
Patients presenting with acute psychosis following sedative use, or those in withdrawal experiencing psychotic symptoms.
Documentation must clearly differentiate between substance-induced symptoms and any underlying psychiatric conditions.
Comprehensive substance use history, including patterns of use, withdrawal symptoms, and treatment responses.
Patients undergoing detoxification who exhibit psychotic symptoms related to sedative use.
Focus on the integration of mental health and addiction treatment plans.
Used during initial evaluation of a patient with suspected substance-induced psychosis.
Comprehensive assessment notes detailing mental status and substance use history.
Psychiatric evaluations must be thorough to support the diagnosis.
F13.25 includes the presence of a psychotic disorder induced by sedative, hypnotic, or anxiolytic use, while F13.20 indicates dependence without such psychotic features.
